The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Propagation of Tau Misfolding from the Outside to the Inside of a Cell
Open accessAbstract
Tauopathies are neurodegenerative diseases characterized by aggregation of the microtubule-associated protein Tau in neurons and glia. Although Tau is normally considered an intracellular protein, Tau aggregates are observed in the extracellular space, and Tau peptide is readily detected in the cerebrospinal fluid of patients. Tau aggregation occurs in many diseases, including Alzheimer disease and frontotemporal dementia. Tau pathology begins in discrete, disease-specific regions but eventually involves much larger areas of the brain. It is unknown how this propagation of Tau misfolding occurs. We hypothesize that extracellular Tau aggregates can transmit a misfolded state from the outside to the inside of a cell, similar to prions. Here we show that extracellular Tau aggregates, but not monomer, are taken up by cultured cells. Internalized Tau aggregates displace tubulin, co-localize with dextran, a marker of fluid-phase endocytosis, and induce fibrillization of intracellular full-length Tau. These intracellular fibrils are competent to seed fibril formation of recombinant Tau monomer in vitro. Finally, we observed that newly aggregated intracellular Tau transfers between co-cultured cells. Our data indicate that Tau aggregates can propagate a fibrillar, misfolded state from the outside to the inside of a cell. This may have important implications for understanding how protein misfolding spreads through the brains of tauopathy patients, and it is potentially relevant to myriad neurodegenerative diseases associated with protein misfolding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pathogenic forms of tau spread toxicity between cells through a prion-like mechanism involving seeded conformational change (Colin et al. 2020, Frost et al. 2009).”
From The Role of Retrotransposons and Endogenous Retroviruses in Age-Dependent Neurodegenerative Disorders (2024) · cites this paper as Frost et al. 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several lines of evidence indicate tau propagates pathology among neurons.”
From Spontaneous pathology in PS19 tauopathy mice progresses via brain networks (2025) · cites this paper as Frost et al., 2009
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Proteopathic tau seeds are capable of entering a cell and promoting aggregation in a prion-like manner (Clavaguera et al., 2009; Frost et al., 2009).”
From Network analysis identifies strain-dependent response to tau and tau seeding-associated genes (2023) · cites this paper as Frost et al., 2009
The cited source says what the claim attributes to it.
In the citing paper
“Tau assemblies enter cells to trigger intracellular aggregation (Frost et al., 2009; Holmes et al., 2014)”
From Spontaneous pathology in PS19 tauopathy mice progresses via brain networks (2025) · cites this paper as Frost et al., 2009
In the citing paper
“The aggregation of tau impairs the axons, leading to neurodegeneration [23].”
From The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment (2022) · cites this paper as [23]
In the citing paper
“The current clinical trial literature is compatible with the idea that AβP-related substances kindle a self-propagating process related to neocortical NFTs, as has been hypothesized (266-269).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [267]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
Tau is a candidate gene for chromosome 17 frontotemporal dementia
Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W. C., Raskind, M., & Schellenberg, G. D. (1998) · Annals of Neurology · doi:10.1002/ana.410430617 · Cited by 1,374
Flagged first, then by citations
Research works printed but not linked: 2
- Delacourte, 2005, Polish Acad. Sci., 43, 244
- DePace, 2002, Nat. Struct. Biol., 9, 389
Cited by
Sorted by citations
Items 901–1,000 of 1,001
Gyparaki, M. T., Arab, A., Sorokina, E. M., Santiago-Ruiz, A. N., Bohrer, C. H., Xiao, J., & Lakadamyali, M. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2020.11.442 · Cited by 8
Spreading of P301S Aggregated Tau Investigated in Organotypic Mouse Brain Slice Cultures
Korde, D. S., & Humpel, C. (2022) · Biomolecules · doi:10.3390/biom12091164 · Cited by 8
Tau seeding activity in various regions of down syndrome brain assessed by two novel assays
Jin, N., Gu, J., Wu, R., Chu, D., Tung, Y. C., Węgiel, J., Wısnıewskı, T., Gong, C., Iqbal, K., & Liu, F. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01436-2 · Cited by 8
Potential of Fluorescent Nanoprobe in Diagnosis and Treatment of Alzheimer’s Disease
Lin, J., Li, H., Guo, J., Xu, Y., Li, H., Yan, J., Wang, Y., Chen, H., & Yuan, Z. (2022) · Nanomedicine · doi:10.2217/nnm-2022-0022 · Cited by 8
Latham, A. S., Geer, C. E., Ackart, D. F., Anderson, I. K., Vittoria, K. M., Podell, B. K., Basaraba, R. J., & Moreno, J. A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1157652 · Cited by 9
No full admission for tau to the exclusive prion club yet
Polanco, J. C., & Götz, J. (2015) · The EMBO Journal · doi:10.15252/embj.201593311 · Cited by 8
Kolay, S., & Diamond, M. I. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.12928 · Cited by 9
Self-citationPathogenese und Prävention des M. Alzheimer
Braak, H., Feldengut, S., & Tredici, K. D. (2013) · Der Nervenarzt · doi:10.1007/s00115-012-3688-1 · Cited by 8
Shapley, S. M., Shantaraman, A., Gadhavi, J. D., Kearney, M. A., Dammer, E. B., Duong, D. M., Bowen, C. A., Watson, C. M., Bagchi, P., Guo, Q., et al. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.101458 · Cited by 9
Proline-Rich Region II (PRR2) Plays an Important Role in Tau–Glycan Interaction: An NMR Study
Murray, A., Yan, L., Gibson, J. M., Liu, J., Eliezer, D., Lippens, G. M., Zhang, F., Linhardt, R. J., Zhao, J., & Wang, C. (2022) · Biomolecules · doi:10.3390/biom12111573 · Cited by 6
Horvat, L. L., Španić, E., Leko, M. B., Zubčić, K., Horvat, L., Mustapić, M., Hof, P. R., & Šimić, G. (2023) · Biomedicines · doi:10.3390/biomedicines11041004 · Cited by 7
β-Bracelets: Macrocyclic Cross-β Epitope Mimics Based on a Tau Conformational Strain
Rajewski, B. H., Makwana, K. M., Angera, I. J., Geremia, D. K., Zepeda, A. R., Hallinan, G. I., Vidal, R., Ghetti, B. F., Serrano, A. L., & Valle, J. R. D. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c06830 · Cited by 8
Kim, D., Huang, Y., & Liu, J. (2025) · NeuroImage · doi:10.1016/j.neuroimage.2025.121142 · Cited by 6
Tittelmeier, J., & Nussbaum-Krammer, C. I. (2025) · Cells · doi:10.3390/cells14110845 · Cited by 11
Venkataraman, L., He, P., Khan, G., Harris, B. T., & Sierks, M. R. (2020) · BMC Neuroscience · doi:10.1186/s12868-020-00586-0 · Cited by 7
Tau Fibrillation Induced by Heparin or a Lysophospholipid Show Different Initial Oligomer Formation
Rasmussen, H. Ø., Nielsen, J., de Poli, A., Otzen, D. E., & Pedersen, J. S. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168194 · Cited by 7
Khanna, S., Selvaraj, D., Tyagi, M., Devadharshini, & Jayaram, S. (2023) · Medicine in Omics · doi:10.1016/j.meomic.2023.100031 · Cited by 7
Age dependent trans-cellular propagation of human tau aggregates in Drosophila disease models
Aqsa, A., & Sarkar, S. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147207 · Cited by 7
The Influence of Extracellular RNA on Cell Behavior in Health, Disease, and Regeneration
Huleihel, L., Scarritt, M. E., & Badylak, S. F. (2017) · Current Pathobiology Reports · doi:10.1007/s40139-017-0121-2 · Cited by 7
Editorial: Tau Propagation Mechanisms: Cell Models, Animal Models, and Beyond
Motoi, Y., Hanger, D. P., & Hasegawa, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00456 · Cited by 7
Brás, I. C., Khani, M., Vasili, E., Möbius, W., Riedel, D., Parfentev, I., Gerhardt, E., Fahlbusch, C., Urlaub, H., Zweckstetter, M., et al. (2021) · bioRxiv · doi:10.1101/2021.07.18.452825 · Cited by 3
Illuminating Tau Aggregates: Multiscale Approaches for Detection, Imaging, and Understanding
Bhuskute, K. R., Fan, J., & Kaur, A. (2025) · Aggregate · doi:10.1002/agt2.70133 · Cited by 6
Toxic mechanisms of amyloid oligomers and therapeutic strategies
Ivanova, M. I., Rosa, C. L., & Ramamoorthy, A. (2026) · Protein Science · doi:10.1002/pro.70519 · Cited by 6
Akbari, V., Bahramikia, S., Jalalvand, A. R., Mehrabi, M., Ezati, M., & Khodarahmi, R. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2273433 · Cited by 6
Diamond, M. I. (2023) · Cytoskeleton · doi:10.1002/cm.21806 · Cited by 5
Self-citationZhan, R., Yan, F., Lou, C.-Y., Chen, N., Mo, X., Jiao, B., Liu, M., Zhao, Y., Xu, W., Xu, H., et al. (2025) · Advanced Science · doi:10.1002/advs.202414397 · Cited by 6
Hagar, H. C., Fernández-Vega, V., Wang, K., Jordan, L. M. O., Shumate, J., Scampavia, L. D., Tapayan, A. S., Nguyen, H. M., Spicer, T., & Kuo, M. (2025) · SLAS DISCOVERY · doi:10.1016/j.slasd.2025.100235 · Cited by 6
Sandhof, C. A., Martin, N., Tittelmeier, J., Schlüter, A., Pezzali, M., Schöndorf, D. C., Lange, T., Reinhardt, P., Ried, J. S., Liang, S., et al. (2025) · Autophagy · doi:10.1080/15548627.2025.2551676 · Cited by 12
The Biology and Pathobiology of Tau Protein
Hall, G. F. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-788-0_15 · Cited by 6
Lyu, D., Gong, M., Zhang, Y., & Lyu, X. (2022) · Systematic Reviews · doi:10.1186/s13643-022-01964-x · Cited by 6
Single Mutations in Tau Modulate the Populations of Fibril Conformers through Seed Selection
Meyer, V., Dinkel, P. D., Luo, Y., Yu, X., Wei, G., Zheng, J., Eaton, G. R., Ma, B., Nussinov, R., Eaton, S. S., et al. (2014) · Angewandte Chemie · doi:10.1002/ange.201308473 · Cited by 6
Levy, S. A., Zuniga, G., Gonzalez, E. M., Butler, D., Temple, S., & Frost, B. E. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2022.100292 · Cited by 6
Self-citationDifferent tau fibril types reduce prion level in chronically and de novo infected cells
Celauro, L., Burato, A., Zattoni, M., Cecco, E. D., Fantuz, M., Cazzaniga, F. A., Bistaffa, E., Moda, F., & Legname, G. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105054 · Cited by 6
Recent advances in nanotechnology for combating Alzheimer's disease
Hu, C., Wu, B., Wu, Y., Shi, M., Ma, J., Gao, H., & Zhang, J. (2023) · Materials Chemistry Frontiers · doi:10.1039/d3qm00493g · Cited by 7
Detection of Glymphatic Outflow of Tau from Brain to Cerebrospinal Fluid in Mice
Ishida, K., & Yamada, K. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3629-9_19 · Cited by 6
Review—Recent Advancements in Neuroelectrochemistry of Disease Biomarkers
Lewis, T., Lucas, S. J., & Martić, S. (2019) · Journal of The Electrochemical Society · doi:10.1149/2.0272003jes · Cited by 6
McCarthy, J. M., Virdee, J. K., Brown, J., Ursu, D., Ahmed, Z., Cavallini, A., & Nuthall, H. N. (2021) · Scientific Reports · doi:10.1038/s41598-021-89230-3 · Cited by 7
Membrane interaction and disulphide-bridge formation in the unconventional secretion of Tau
Hellén, M., Bhattacharjee, A., Uronen, R., & Huttunen, H. J. (2021) · Bioscience Reports · doi:10.1042/bsr20210148 · Cited by 6
Ways to stop the spread of Alzheimer’s disease
Costandi, M. (2018) · Nature · doi:10.1038/d41586-018-05723-8 · Cited by 6
The Role of Glycogen Synthase Kinase-3 (GSK-3) in Alzheimer’s Disease
Medina, M., & Avil, J. (2011) · InTech eBooks · doi:10.5772/16879 · Cited by 7
Inert and seed-competent tau monomers suggest structural origins of aggregationPreprint
Mirbaha, H., Chen, D., Morozova, O. A., Ruff, K. M., Sharma, A., Liu, X., Pappu, R. V., Colby, D. W., Mirzaei, H., Joachimiak, Ł. A., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/163394 · Cited by 10
Self-citationLRP1 and SORL1 regulate tau internalization and degradation and enhance tau seedingPreprint
Cooper, J. M., Lathuilière, A., Migliorini, M. M., Arai, A. L., Wani, M. M., Dujardin, S., Muratoglu, S. C., Hyman, B. T., & Strickland, D. K. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.17.386581 · Cited by 6
Spontaneous pathology in PS19 tauopathy mice progresses via brain networks
Ramirez, D. M. O., Whitesell, J. D., Bhagwat, N., Thomas, T. L., Ajay, A. D., Nawaby, A., Delatour, B., Bay, S., LaFaye, P., Harris, J. A., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107072 · Cited by 5
Self-citationRational Modulation of Liquid–Liquid Phase Separation Offers Novel Ways to Combat Tauopathies
Zhang, X., Wang, L., Lin, N., Gao, M. Y., & Huang, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146709 · Cited by 7
Tau biology, biomarkers, and therapeutics
Frost, B. E., Kolb, H. C., Algeciras‐Schimnich, A., Betthauser, T. J., DeVos, S. L., Edelmayer, R. M., Elwood, F., Fleisher, A., Henley, D. B., Horie, K., et al. (2025) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70165 · Cited by 7
Self-citationRole of Leptin and Adiponectin in the Management of Alzheimer's Disease: A Systematic Review
Adil, M., Ghulammohiuddin, F., & Khalid, N. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70326 · Cited by 5
Network Models of Neurodegeneration: Bridging Neuronal Dynamics and Disease Progression
Alexandersen, C. G., Brennan, G. S., Brynildsen, J. K., Henderson, M. X., Iturria‐Medina, Y., & Bassett, D. S. (2026) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2025.3643310 · Cited by 9
Tau in Multiple Sclerosis: A Review of Therapeutic Potential
Hoehne, C. L., Stüve, O., & Stopschinski, B. E. (2025) · Current Treatment Options in Neurology · doi:10.1007/s11940-024-00820-8 · Cited by 6
Structural changes to the basal forebrain cholinergic system in the continuum of Alzheimer disease
Taza, M., Schmitz, T. W., & Spreng, R. N. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19088-9.00013-5 · Cited by 7
Weidling, I. W., Preiss, C. N., Chancellor, S. E., Srivastava, G. P., Gibilisco, L., Lin, G., Brennan, M. S., Lee, J. Y., Roth, L. M., Morozova, O., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02000-4 · Cited by 5
Ayurvedic herbs–derived cognitive enhancers for the management of Alzheimer's disease (AD)
Muralidhara, M., & Rajini, P. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19084-1.00002-8 · Cited by 4
Conger, N., Osmani̇ye, D., Sağlık, B. N., Levent, S., Özkay, Y., & Kaplancıklı, Z. A. (2023) · Journal of Molecular Recognition · doi:10.1002/jmr.3059 · Cited by 5
Soeda, Y., Hayashi, E., Nakatani, N., Ishigaki, S., Takaichi, Y., Tachibana, T., Riku, Y., CHAMBERS, J. K., Koike, R., Mohammad, M., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-65949-7 · Cited by 5
An autopsy case of progressive supranuclear palsy treated with monoclonal antibody against tau
Beck, G., Yamashita, R., Kido, K., Ikenaka, K., Chiba, T., Yonenobu, Y., Saito, Y., Morii, E., Hasegawa, M., Murayama, S., et al. (2023) · Neuropathology · doi:10.1111/neup.12890 · Cited by 5
Genetics of Frontotemporal Dementia
Heetveld, S., Rizzu, P., & Heutink, P. (2015) · Springer eBooks · doi:10.1007/978-3-319-17223-1_5 · Cited by 5
Is tau a suitable therapeutical target in tauopathies?
de Barreda, E. G. (2010) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v1.i5.81 · Cited by 5
Desale, S. E., & Chinnathambi, S. (2020) · doi:10.21203/rs.3.rs-22830/v1 · Cited by 5
Jin, B., Brown, K. S.-M., Smirnov, D. S., Naik, S. M., Kirkham, S. L., Hennessey, E. L., Dong, G., Mao, S., Wijethunga, S. P., Connors, T. R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.26.656152 · Cited by 6
Swain, S., Sen, A., & Metya, A. K. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2024.2306200 · Cited by 4
Hossain, M. K., & Chae, H. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105905 · Cited by 5
Seeding biosensor cell line that reproduces the Alzheimer tau fold
Katsinelos, T., Lövestam, S., Qi, C., Falcon, B., Macdonald, J. A., Stephenson, G., Ghetti, B. F., McKee, A. C., Scheres, S. H. W., & Goedert, M. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110952 · Cited by 4
Could it be that neurodegenerative diseases are infectious?
Derkinderen, P. (2019) · Revue Neurologique · doi:10.1016/j.neurol.2019.07.003 · Cited by 4
Tau and Alzheimer’s Disease: Molecular Mechanisms and Treatment Approaches
Reiss, A. B., Muhieddine, D., Leon, A. Z. D., Voloshyna, I., Gomolin, I. H., & Pinkhasov, A. (2021) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-021-01092-y · Cited by 4
α‐Synuclein Drives Tau's Cytotoxic Aggregates Formation through Hydrophobic Interactions
Ojeda, A. M., Cofré, V., Melo, F., Caballero, L., Fuentealba, D., & Cornejo, A. (2023) · ChemPlusChem · doi:10.1002/cplu.202300257 · Cited by 5
Ginsenosides Decrease β-Amyloid Production via Potentiating Capacitative Calcium Entry
Cho, Y. Y., Park, J. H., Lee, J. H., & Chung, S. (2024) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2023.172 · Cited by 4
Bitan, F. R. A. G. (2014) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781608058525114020014 · Cited by 4
Dickerson, B. C. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781316091586.016 · Cited by 4
Passive Immunotherapy in Alzheimer’s Disease
Dolan, P. J., & Zago, W. M. (2018) · InTech eBooks · doi:10.5772/intechopen.76299 · Cited by 4
Daneshvar, D. H., & McKee, A. C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-398270-4.00016-1 · Cited by 3
Tau Seeds in Extracellular Vesicles Induce Tau Accumulation in Degradative Organelles of Cells
Pedrioli, G., Barberis, M., Magrin, C., Morone, D., Piovesana, E., Senesi, G., Sola, M., Papin, S., & Paganetti, P. (2021) · DNA and Cell Biology · doi:10.1089/dna.2021.0485 · Cited by 4
Generation, Purification, and Characterization of Cell-invasive DISC1 Protein Species
Bader, V., Ottis, P., Pum, M. E., Huston, J. P., & Korth, C. (2012) · Journal of Visualized Experiments · doi:10.3791/4132-v · Cited by 4
Rahman, M. M., Islam, M. R., Tumpa, M. A. A., Shohag, S., shuvo, S. K., Ferdous, J., Kajol, S. A., Aljohani, A. S. M., Abdulmonem, W. A., Rauf, A., et al. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110375 · Cited by 4
New developments in prion disease research
Gilch, S., & Schätzl, H. M. (2023) · Cell and Tissue Research · doi:10.1007/s00441-023-03760-y · Cited by 4
Roles of microRNAs in Parkinson’s and other neurodegenerative diseases
Lai, Q., Murgia, N., Parkkinen, I., Domanskyi, A., & Vinnikov, I. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815669-8.00008-7 · Cited by 4
In vitro recapitulation of aberrant protein inclusions in neurodegenerative diseases
Nonaka, T., & Hasegawa, M. (2011) · Communicative & Integrative Biology · doi:10.4161/cib.15779 · Cited by 4
“Hot Spots” in Medicinal Chemistry
Metternich, R. E., & Tarzia, G. (2010) · ChemMedChem · doi:10.1002/cmdc.201000266 · Cited by 4
Potential neuroprotective strategies against tauopathy
Wheeler, J. M., Guthrie, C. R., & Kraemer, B. C. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120017 · Cited by 4
Genetic risk factors of Alzheimer's disease and cell-to-cell transmission of Tau
Huttunen, H. J. (2016) · Journal of Neurology and Neuromedicine · doi:10.29245/2572.942x/2016/2.1022 · Cited by 4
Minimalistic in vitro systems for investigating tau pathology
Hallinan, G. I., Pitera, A. P., Patel, P., West, J. J., & Deinhardt, K. (2018) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2018.09.032 · Cited by 4
Vespa, P. M., Hirt, D., & Manley, G. T. (2016) · Neurosurgery Clinics of North America · doi:10.1016/s1042-3680(16)30053-5 · Cited by 4
Primio, C. D., Quercioli, V., Siano, G., Kováčech, B., Novák, M., & Cattaneo, A. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/041756 · Cited by 4
Extracellular Vesicles Hijack the Autophagic Pathway to Induce Tau Accumulation in EndolysosomesPreprint
Pedrioli, G., Barberis, M., Molinari, M., Morone, D., Papin, S., & Paganetti, P. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.27.118323 · Cited by 4
Anderson, J. A. E., Schifani, C., Nazeri, A., Voineskos, A. N., & Initiative, A. D. N. (2021) · medRxiv · doi:10.1101/2021.03.26.21254351 · Cited by 4
Size-dependent secondary nucleation and amplification of α-synuclein amyloid fibrilsPreprint
Sakunthala, A., Datta, D., Navalkar, A., Gadhe, L. G., Kadu, P., Patel, K., Mehra, S., Kumar, R., Chatterjee, D., Sengupta, K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.28.474324 · Cited by 4
Tau seeds translocate across the cell membrane to initiate aggregationPreprint
Dodd, D. A., LaCroix, M., Valdez, C., Knox, G. M., Vega, A. R., Kumar, A., Xing, C., White, C. L., & Diamond, M. I. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.10.491429 · Cited by 4
Self-citationZeng, Z., Tsay, K., Vijayan, V., Frost, M. P., Prakash, S., Quddus, A., Albert, A., Vigers, M. P., Srivastava, M., Woerman, A. L., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.19.549721 · Cited by 4
Network analysis identifies strain-dependent response to tau and tau seeding-associated genes
Acri, D. J., You, Y., Tate, M. D., Karahan, H., Martinez, P., McCord, B., Sharify, A. D., John, S., Kim, B., Dabin, L. C., et al. (2023) · Journal of Experimental Medicine · doi:10.1084/jem.20230180 · Cited by 3
“Proteopathic tau seeds are capable of entering a cell and promoting aggregation in a prion-like manner (Clavaguera et al., 2009; Frost et al., 2009).”
Alzheimer’s disease and the mathematical mind
Thompson, T., Vigil, B. Z., & Young, R. S. K. (2024) · Brain Multiphysics · doi:10.1016/j.brain.2024.100094 · Cited by 3
Zhang, D.-Q., Yang, X., Niu, H.-B., Sun, X.-C., Cao, D., Li, A., Yue, J., Li, X.-L., & Zhang, Q. (2025) · Current Alzheimer Research · doi:10.2174/0115672050351995241223065923 · Cited by 3
Zhang, C., Tai, Y., Kong, M., Jia, P., Ma, G., Ba, M., & Initiative, A. D. N. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251322196 · Cited by 5
Bhandari, A. K., Dhami, A. S., Hemanthlumar, R. T., Mishra, N., Joslyn, B., Roy, S., Srinivasan, J., Prajapati, K. P., Kar, K., & Anand, B. G. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102879 · Cited by 4
Tau seeding activity in Alzheimer's disease: Characteristics, factors, and applications
Liu, Y., Chen, Y., Chen, Z., Wan, H., & Wu, C. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251378772 · Cited by 4
In Vitro and In Vivo Evaluation of Small-Molecule Disassemblers of Pathological Tau Fibrils
Pan, H., Cheng, X., Zhang, J., Hou, K., Murray, K. A., Manglani, K., Zhu, C., Hsu, H., Mekkittikul, M., Halladay, T., et al. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00940 · Cited by 3
Saleem, T., Möbius, W., Schmitz, M., Correia, A. D. S., Thomas, C., Canaslan, S., Hermann, P., Goebel, S., Zafar, S., Root, E., et al. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-02998-4 · Cited by 4
Lopez, D. M., Maltby, C. J., Warming, H., Divecha, N., Vargas‐Caballero, M., Coldwell, M. J., & Deinhardt, K. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1196007 · Cited by 4
Rabanal‐Ruiz, Y., Pedrero-Prieto, C. M., Rodríguez, L. S., Flores‐Cuadrado, A., Saiz‐Sánchez, D., Frontiñán-Rubio, J., Úbeda‐Bañón, I., Durán‐Prado, M., Martínez-Marcos, A., & Peinado, J. R. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167204 · Cited by 3
Huang, Y., Dan, T., Kim, W. H., & Guorong Wu, A. (2024) · Lecture notes in computer science · doi:10.1007/978-3-031-72069-7_47 · Cited by 3
Sigurdsson, E. M. (2016) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-3560-4_8 · Cited by 3
Das‐Earl, P., Schreihofer, D. A., Sumien, N., & Schreihofer, A. M. (2024) · Journal of Neurophysiology · doi:10.1152/jn.00409.2023 · Cited by 3
Feleke, R., Jogaudaite, S., Velentza‐Almpani, E., Yeung-Yeung, L., Clode, D., Ko, J. H., Shin, B., Matthews, S., Otero‐Jimenez, M., Wojewska, M. J., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02869-4 · Cited by 4
Metadata
- Authors
- Frost, B., Jacks, R. L., & Diamond, M. I.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Diamond, Marc I.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 284
- Issue
- 19
- Pages
- 12845-12852
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2676015
- OpenAlex
- W1989208474
- Cited by
- 1,252
- References
- 32
- Citations by year
- 2026: 34 · 2025: 71 · 2024: 76 · 2023: 78 · 2022: 72 · 2021: 96 · 2020: 97 · 2019: 70 · 2018: 67 · 2017: 76 · 2016: 67 · 2015: 83 · 2014: 78 · 2013: 89 · 2012: 81
- FWCI
- 43.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Muscular Dystrophy Association
- National Institutes of Health
- University of California, San Francisco
- National Institute of Neurological Disorders and Stroke (R01NS050284, R01 NS50284-03)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tauopathy, prion-like propagation, fluid-phase endocytosis, Alzheimer's disease, frontotemporal dementia
- MeSH terms
- Animals, Animals, Newborn, Cell Line, Dextrans, Extracellular Space, Flow Cytometry, Fluorescent Antibody Technique, Humans, Kidney, Luminescent Proteins, Neurons, Stem Cells, Blotting, Western, tau Proteins, Protein Folding, Microscopy, Atomic Force, Coculture Techniques, Intracellular Space, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
